Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3917 results

Sort By:

Critical Care Optimized Pediatric and Neonatal Quantitative Neuromonitoring

Study ID: NCT06726408
Start Date: 2025-09-01
End Date: 2026-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Neuromonitoring with 10 electrodes

Sponsor

Nantes University Hospital

Source: clinicaltrials.gov

Share:
Add to list

CAffeine Use in Prolonged Oxygen Use in meConium aspIration Syndrome in Neonatal Outcomes (CAPUCINO)

Study ID: NCT06972108
Start Date: 2025-09-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Caffeine citrate

Saline (NaCl 0,9 %) (placebo)

Sponsor

University of Alberta

Source: clinicaltrials.gov

Share:
Add to list

Improving Iron Levels in Female Endurance, Intermittent, and Power/Strength Athletes Aged 16-35

Study ID: NCT06942208
Start Date: 2025-09-01
End Date: 2026-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

36

Intervention / Treatment

Low-dose iron (ferrous sulfate)

Yeast-bound iron (ferrous sulfate)

High-dose iron (ferrous sulfate)

Sponsor

University of Calgary

Source: clinicaltrials.gov

Share:
Add to list

Impact of Exogenous Ketones on Sleep Apnea

Study ID: NCT06687655
Start Date: 2025-09-01
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

Ketone-IQ

Placebo

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia

Study ID: NCT07071155
Start Date: 2025-11-05
End Date: 2028-05-30
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

18

Intervention / Treatment

Momothy

Azacitidine

Decitabine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Source: clinicaltrials.gov

Share:
Add to list

Stripping Massage Technique and Post-isometric Relaxation

Study ID: NCT07063355
Start Date: 2025-07-24
End Date: 2025-10-20
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

44

Intervention / Treatment

Stripping Massage Technique:

Post-Isometric Relaxation (PIR)

Sponsor

Riphah International University

Source: clinicaltrials.gov

Share:
Add to list

Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway

Study ID: NCT07024550
Start Date: 2025-07-22
End Date: 2026-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

Treatment with BTL-699-2 device

Treatment with BTL-699-2 device with intensity below therapeutic threshold

Sponsor

BTL Industries Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion

Study ID: NCT06369350
Start Date: 2025-12
End Date: 2027-09
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

30

Intervention / Treatment

Vitamin B6 25 MG

Vitamin B6 50 MG

Vitamin B6 100 MG

Placebo

Sponsor

Milton S. Hershey Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Preoperative Point of Care Ultrasound Guided Fluid Optimization and Intravenous Ondansetron to Prevent General Anesthesia-Induced Hypotension

Study ID: NCT05784350
Start Date: 2025-08-01
End Date: 2028-05-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

fluid boluses guided by IVC diameter via US/administration of pre-operative IV Odansetrone

Sponsor

Meir Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

Study ID: NCT06959550
Start Date: 2025-10-01
End Date: 2030-07-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Ivonescimab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list